Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1680581 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.62Day −2.69%Mkt cap $241M1Y −52.3%Off 52W high −77.0%Vol (1Y) 99.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,764 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.4% of sh out |
| Days to cover4.0d |
| 13F net flow (QoQ)+3.04% |
| Top-10 13F concentration54.3% |
| Next report (est.)2026-10-28 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$76.1M |
| ROE−25.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−68.0% |
| 1Y−52.3% |
| 3Y−5.2% |
| 5Y−51.6% |
| Since incept. (ann.)−17.1% |
Total return through 2026-07-29 · series begins 2019-07-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)99.7% |
| Ann. volatility (3Y)95.1% |
| Sharpe (1Y)−0.23 |
| Sharpe (3Y)0.51 |
| Max drawdown (1Y)−78.5% |
| Max drawdown (3Y)−79.1% |
| Beta (3Y vs SPY)2.57 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.6M | $50M | 9.85% | +0.0% |
| RA CAPITAL MANAGEMENT, L.P. | 6.1M | $46M | 9.09% | +0.0% |
| BlackRock, Inc. | 5.4M | $41M | 8.09% | +26.4% |
| TCG Crossover Management, LLC | 5.3M | $40M | 7.88% | +0.0% |
| BRAIDWELL LP | 3.1M | $24M | 4.70% | +2.4% |
| Nantahala Capital Management, LLC | 3.1M | $23M | 4.58% | −29.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $21M | 4.04% | new |
| Siren, L.L.C. | 2.4M | $18M | 3.53% | +20.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 107.6% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 7,967,121 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-27 | −$0.25 | — | — | — |
| 2025-09-30 | 2025-10-29 | −$0.31 | — | $0 | — |
| 2025-06-30 | 2025-07-29 | −$0.28 | −132.2% | $0 | −100.0% |
| 2025-03-31 | 2025-05-01 | −$0.28 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-28 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
